Cailong Pharmaceutical: Announcement of Board Resolutions
Cailong Pharmaceutical: Announcement of Supervisory Board Resolutions
Sailong Pharmaceutical: Announcement of Resolutions of the Fifth Meeting of the Fourth Board of Supervisors
Sailong Pharmaceutical: Announcement of Resolutions of the Fourth Meeting of the Fourth Board of Supervisors
Sailong Pharmaceutical: Announcement of Resolutions of the Fifth Meeting of the Fourth Board of Directors
Sailong Pharmaceutical: Announcement on stock price changes
Cailong Pharmaceuticals: Announcement on Accepting Subsidiary Guarantees
Sailong Pharmaceutical: Semi-Annual Report Board Resolution Announcement
Sailong Pharmaceutical: Announcement on the company\'s application for credit from the bank and the actual controller providing a guarantee
Cailong Pharmaceuticals: Articles of Association (August 2024)
Sailong Pharmaceutical: Semi-Annual Report Supervisory Board Resolutions Announcement
Sailong Pharmaceutical: Announcement on renewing the Company\'s 2024 Audit Institution
Sailong Pharmaceutical: Review Opinions of the 2nd Meeting of the 4th Special Meeting of Independent Directors of the Board of Directors in 2024
Sailong Pharmaceutical Group: Announcement Regarding Stock Price Volatility
Sailong Pharmaceutical Group: Announcement of the resolution of the third meeting of the fourth session of the board of directors.
Sailong Pharmaceutical Group: Company bylaws (July 2024)
Sailong Pharmaceutical Group: 002898 Cailong Pharmaceutical Investor Relations Management Information 20240514
Sailong Pharmaceutical Group: Announcement on holding the 2023 Online Results Briefing
Sailong Pharmaceutical: Annual Special Audit Report on Related Party Capital Occupation
Sailong Pharmaceutical: “Independent Director Work System”
No Data